Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRESCO: FMT or FMFT for Chronic Active Ulcerative Colitis
NCT03843385Phase 3Active, not recruiting
- Start
- Jan 2023
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ulcerative colitis (UC) (3 arms). Primary endpoint: Clinical Remission at 12 weeks. Started Jan 2023; status: active, not recruiting.
02
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03843385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03843385.